Proprotein convertase subtilisin/kexin type 9 (PCSK9) affects gene expression pathways beyond cholesterol metabolism in liver cells
Lan Hong(Yanbian University), Joseph A. Hedrick, Gladys Arreaza(Merck & Co., Inc., Rahway, NJ, USA (United States)), Vidhi Shah(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marco Hernandez(Merck & Co., Inc., Rahway, NJ, USA (United States)), Harry R. Davis(AIL Research (United States)), Marsha M. Smith(Merck & Co., Inc., Rahway, NJ, USA (United States)), Diane Levitan, Jonathan Greene(Claremont Graduate University), Qing Zhang(Sichuan International Studies University), Wei Ding(Ministry of Education of the People's Republic of China), Ling Pang, Maureen Laverty, Li-Xin Shan, Eric L. Gustafson(Functional Technologies (United Kingdom)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Li Liu(Chinese Academy of Medical Sciences & Peking Union Medical College), Marvin Bayne(Unknown)
Cited by 90
Related Papers
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Selective small-molecule inhibition of an RNA structural element
|Nature|2015|419
Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation
|Biochemical Journal|2006|272
Identification of Urotensin II as the Endogenous Ligand for the Orphan G-Protein-Coupled Receptor GPR14
|Biochemical and Biophysical Research Communications|1999|241